Changes in the Electrically Evoked Compound Action Potential over time After Implantation and Subsequent Deafening in Guinea Pigs

• Published in: Journal of the Association for Research in Otolaryngology Vol. 23; no. 6; pp. 721 - 738
• Main Authors: Ramekers, Dyan, Benav, Heval, Klis, Sjaak F. L., Versnel, Huib
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2022; Springer Nature B.V
• Subjects: Action potential; Action Potentials - physiology; Animals; Auditory nerve; Cochlea; Cochlear Implantation - methods; Cochlear Implants; Cochlear Nerve - physiology; Deafness; Electric Stimulation; Electrical stimuli; Evoked Potentials; Evoked Potentials, Auditory - physiology; Excitability; Guinea Pigs; Hearing loss; Humans; Latency; Medicine; Medicine & Public Health; Neurobiology; Neurodegeneration; Neurosciences; Otorhinolaryngology; Research Article; Spiral ganglion; Spiral Ganglion - physiology; Young Adult; Cochlear implant; Cochlear health; eCAP; Neurodegeneration; Auditory nerve; Hearing loss
• ISSN: 1438-7573; 1525-3961; 1438-7573
• DOI: 10.1007/s10162-022-00864-0

The electrically evoked compound action potential (eCAP) is a direct measure of the responsiveness of the auditory nerve to electrical stimulation from a cochlear implant (CI). CIs offer a unique opportunity to study the auditory nerve’s electrophysiological behavior in individual human subjects over time. In order to understand exactly how the eCAP relates to the condition of the auditory nerve, it is crucial to compare changes in the eCAP over time in a controlled model of deafness-induced auditory nerve degeneration. In the present study, 10 normal-hearing young adult guinea pigs were implanted and deafened 4 weeks later, so that the effect of deafening could be monitored within-subject over time. Following implantation, but before deafening, most examined eCAP characteristics significantly changed, suggesting increasing excitation efficacy (e.g., higher maximum amplitude, lower threshold, shorter latency). Conversely, inter-phase gap (IPG) effects on these measures – within-subject difference measures that have been shown to correlate well with auditory nerve survival – did not vary for most eCAP characteristics. After deafening, we observed an initial increase in excitability (steeper slope of the eCAP amplitude growth function (AGF), lower threshold, shorter latency and peak width) which typically returned to normal-hearing levels within a week, after which a slower process, probably reflecting spiral ganglion cell loss, took place over the remaining 6 weeks (e.g., decrease in maximum amplitude, AGF slope, peak area, and IPG effect for AGF slope; increase in IPG effect for latency). Our results suggest that gradual changes in peak width and latency reflect the rate of neural degeneration, while peak area, maximum amplitude, and AGF slope reflect neural population size, which may be valuable for clinical diagnostics.